Проект клинических рекомендаций рон тактика ведения доношенных и недоношенных новорожденных детей с непрямой гипербилирубинемией 24. 10. 2016

Проект клинических рекомендаций РОН
Тактика ведения доношенных и недоношенных новорожденных детей
с непрямой гипербилирубинемией 24.10.2016
42 Российское общество неонатологов
29.
Maisels MJ. Neonatal Jaundice. In: Sinclair JC, Bracken MB, eds. Effective care of the newborn infant. Oxford, UK: Oxford University Press, 1992:507.
30.
Newman ТВ, Liljestrand P, Escobar GJ. Jaundice noted in the first 24 hours after birth in a managed care organization. Arch Pediatr Adolesc Med 2002; 156:1244.
31.
Knudsen A. Prediction ofthe development of neonatal jaundice by increased umbilical cord blood bilirubin. Acta Paediatr Scand 1989; 78:217.
32.
Newman ТВ, Xiong B, Gonzales VM, et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr
AdolescMed2000,IMA 140.
33.
Maisels MJ, DeRidder JM, Kring EA, et al. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol 2009; 29:612.
34.
Yamauchi Y, Yamanouchi I. Difference in TcB readings between full term newborn infants born vaginally and by cesarean section. Acta Paediatr Scand 1989;78:824.
35.
Amato M, Fouchere JC, von Muralt G. Relationship between peri-intraventricular hemorrhage and neonatal hyperbilirubinemia in very low birth weight infants. Am J
Perinatol 1987;4:275.
36.
Silverman WA A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1998;
102:225 (supplement).
37.
Keren R, Luan X, Friedman S, et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 2008; 121 :e170.
38.
Bertini G, Dani C, Trochin M, etal. Is breastfeeding really favoring early neonatal jaundice? Pediatrics 2001;107.
39.
Yamauchi Y, Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics 1990;86:171.
40.
Gartner U, Goeser T, Wolkoff AW. Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology 1997; 113:1707.
41.
Maisels MJ, Kring EA. Length of stay, jaundice and hospital readmission. Pediatrics
1998; 101:995.
42.
McDonald SJ, Middleton P. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev 2008;
16(2):CD004074.
43.
Saigal S, O'Neill A, Surainder Y, et al. Placental transfusion and hyperbilirubinemia in the premature. Pediatrics 1972;49:406.
44.
Black VD, Lubchenco LO, Koops BL, et al. Neonatal hyperviscosity: randomized study of effect of partial plasma exchange transfusion on longterm outcome. Pediatrics
1985;75:1048 45.
Goldberg K, Wirth FH, Hathaway WE, et al. Neonatal hyperviscosity II. Effect of partial plasma exchange transfusion. Pediatrics 1982;69:419.
46.
Ultee CA, van der Deure J, Swart J, et al. Delayed cord clamping in preterm infants delivered at 34-36 weeks' gestation: a randomised controlled trial. Arch Dis Child Fetal
Neonatal Ed 2008;93(1 ):F20.
47.
Frishberg Y, Zelicovic I, Merlob P, et al. Hyperbilirubinemia and influencing factors in term infants. IsrJ Med Sci 1989;25:28.
48.
Jahrig D, Jahrig K, Striet S, et al. Neonatal jaundice in infants of diabetic mothers. Acta
Paediatr Scand Suppl 1989;360:101.

Проект клинических рекомендаций РОН
Тактика ведения доношенных и недоношенных новорожденных детей
с непрямой гипербилирубинемией 24.10.2016
43 Российское общество неонатологов
49.
Jahrig D, Jahrig K, Striet S, et al. Neonatal jaundice in infants of diabetic mothers. Acta
Paediatr Scand Suppl 1989;360:101.
50.
Berk MA Mimouni F, Miodovnik M, et al. Macrosomia in infants of insulin-dependent diabetic mothers. Pediatrics 1989;83:1029.
51.
Chavalitdhamrong P-O, Escobedo MB, Barton LL, et al. Hyperbilirubinemia and bacterial infection in the newborn. Arch Dis Child 1975;50:652.
52.
Linder N, Yatsiv I, Tsur M, etal. Unexplained neonatal jaundice as an early diagnostic sign ofsepticemia in the newborn. J Perinatol 1988;8:325.
53.
Garcia FJ, Nager AL. Jaundice as an early diagnostic sign of urinary tract infection in infancy. Pediatrics 2002; 109: 6.
54.
Maisels MJ, Newman ТВ. Neonatal jaundice and urinary tract infections. Pediatrics
2003^ 12:1213.
55.
Kaplan M, Hammerman C. Hemolytic disorders and their management. In: Stevenson
DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw
Hill, 2012:145.
56.
Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase-deficient neonates: a potential cause for concern in North America. Pediatrics 2000; 106:1478.
57.
Kaplan M, Algur N, Hammerman C. Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2001; 108:956.
58.
Kaplan M, Beutler E, Vreman HJ, et al. Neonatal hyperbilirubinemia in glucose-6- phosphate dehydrogenase deficient heterozygotes. Pediatrics 1999; 104:68.
59.
Kaplan M, Hammerman C, Renbaum P, et al. Differing pathogenesis of perinatal bilirubinemia in glucose-6-phosphate dehydrogenase-deficient versus normal neonates.
Pediatr Res 2001;50:532.
60.
Bender GJ, Cashore WJ, Oh W. Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics
2007;'120:1067.
61.
Ross ME, Waldron PE, Cashore WJ, et al. Hemolytic disease of the fetus and newborn.
In: de Alarcon PA, Werner EJ, Christensen RD, eds. Neonatal hematology, pathogenesis, diagnosis, and management of hematologic problems, 2nd ed. Cambridge UK:
Cambridge University Press, 2013:65.
62.
Gallagher PG. Disorders of erythrocyte metabolism and shape. In: Christensen RD, ed.
Hematologic problems of the neonate. Philadelphia, PA W.B. Saunders Co, 2000:209.
63.
Christensen RD, Henry E. Hereditary spherocytosis in neonates with hyperbilirubinemia.
Pediatrics 2010; 125:120.
64.
Black VD, Lubchenco LO, Luckey DW, et al. Developmental and neurologic sequelae in the neonatal hyperviscosity syndrome. Pediatrics 1982;69:426.
65.
Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinaemia in the era of genomics. Semin Neonatol 2002;7:143.
66.
Kaplan M, Hammerman C, Maisels MJ. Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics 2003; 111:886.
67.
Job H, Hart G, Lealman G. Improvements in long term phototherapy for patients with
Crigler-Najjar syndrome type I. Phys Med Biol 1996;41 (11 ):2549.
68.
Fox IJ, Roy-Chowdhury J, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422.
69.
Vaz AR, Delgado-Esteban M, Brito MA, et al. Bilirubin selectively inhibits cytochrome с oxidase activity and induces apoptosis in immature cortical neurons: assessment of the protective effects of glycoursodeoxycholic acid. J Neurochem 2010; 112:56.
70.
Wennberg RP. Cellular basis of bilirubin toxicity. NY State J Med 1991 ;91:493

Проект клинических рекомендаций РОН
Тактика ведения доношенных и недоношенных новорожденных детей
с непрямой гипербилирубинемией 24.10.2016
44 Российское общество неонатологов
71.
Seidman DS, Paz I, Stevenson DK, et al. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics 1991 ;88:828.
72.
Maisels MJ, Newman ТВ. Bilirubin and neurological dysfunction—do we need to change what we are doing? Pediatr Res 2001;50(6):677.
73.
Grimmer I, Berger-Jones K, Buhrer C, et al. Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr 1999;88:661.
74.
Heimler R, Sasidharan P. Neurodevelopmental and audiological outcome of healthy term newborns with moderately severe non-haemolytic hyperbilirubinemia. J Paediatr Child
Health 2010;46:588.
75.
Watchko JF, Tiribelli C., N Engl J Med. 2013 Nov;369(21):2021-30. Bilirubin-induced neurologic damage--mechanisms and management approaches.
76.
Okumura A, Kidokoro H, Shoji H, et al. Kernicterus in preterm infants. Pecfafn'cs 2009;
123:e1052 77.
Huang M-J, Kua K-E, Teng H-C, et al. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res 2004;56:682.
78.
Cottrell BH, Anderson GC. Rectal or axillary temperature measurement: effect on plasma bilirubin and intestinal transit of meconium. J Pediatr Gastroenterol Nutr 1984;3:734 79.
Knudsen A. The influence ofthe reserve albumin concentration and pH on the cephalocaudal progression of jaundice in newborns. Early Hum Dev 1991 ;25:37.
80.
Watchko JF, Kaplan M, Stark AR, et al. Should we screen newborns for glucose-6- phosphate dehydrogenase deficiency in the United States? J Perinatol 2013;33:499.
81.
Robertson A, Carp W, Broderson R. Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand 1991 ;80:1119.
82.
Watchko JF, Maisels MJ. Jaundice in low birth weight infants—pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed2003;88:F455.
83.
HackM, Wilson-Costello D, Friedman H, etal. Neurodevelopmentand predictors ofoutcomes ofchildren with birth weights ofless than 1000 g: 19921995. Arch Pediatr
Adolesc Med2000; 154:725.
84.
DeVries KL, Lary S, Dubowitz LMS. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 1985;76:351.
85.
Morris BH, Oh W, Tyson JE, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 2008;359:1885.
86.
Wagle S., Deshpande P.G., Itani O., Windle M.L., Clark D.A., Wagner C.l. Rosenkrantz
T. Hemolytic Disease of Newborn. Updated: Sep 26, 2014. https://emedicine.medscape.com/article/974349)
87.
Amin SB, Charafeddine L, Guillet R. Transient bilirubin encephalopathy and apnea of prematurity in 28 to 32 weeks gestational age infants. J Perinatol 2005;25:386.
88.
Nakamura H, Takada S, Shimabuku R, et al. Auditory and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 1985;75:703.
89.
Shapiro SM. Kernicterus. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care of the jaundiced neonate. New York, NY: McGraw Hill, 2012:229.
90.
Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal
Neonatal Med2010;15:157.
91.
Ip S, Glicken S, Kulig J, et al. Management of neonatal hyperbilirubinemia. Rockville,
MD: U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality. AHRQ Publication, 200303.
92.
Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present and future.
Pediatrics 1992;90:707.

Проект клинических рекомендаций РОН
Тактика ведения доношенных и недоношенных новорожденных детей
с непрямой гипербилирубинемией 24.10.2016
45 Российское общество неонатологов
93.
Johnson L, Brown AK, Bhutani VK. Bind—a clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics 1999;104:746.
94.
Johnson L1, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot
USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009 Feb;29 Suppl 1:S25-45. doi:
10.1038/jp.2008.211.
95.
Maisels MJ, Clune S, Coleman K, et al. The natural history of jaundice in predominantly breast-fed infants. Pediatrics 2014. doi: 10.1542/peds.2013- 4299 96.
Davis AR, Rosenthal P, Escobar G, et al. Interpreting conjugated bilirubin levels in newborns. J Pediatr 2011; 158:562.
97.
Maisels MJ, Baltz RD, Bhutani V, et al. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114:297.
98.
Kramer LI. Advancement of Dermal Icterus in the Jaundiced Newborn. Amer J Dis
Child. 1969; 118: 454-458 99.
Maisels MJ, Bhutani VK, Bogen D, et al. Hyperbilirubinemia in the newborn infant > 35 weeks' gestation: an update with clarifications. Pediatrics 2009; 124(4):1193.
100.
Jaundice in newborn babies under 28 days. Neonatal jaundice. National Institute for Health and Clinical Excellence, 2010;
101.
Bhutani VK, Stark AR et al. Predischarge Screening for Severe Neonatal
Hyperbilirubinemia Identifies Infants Who Need Phototherapy. Department of Neonatal and Developmental Medicine, Lucile Packard Children's Hospital, Department of
Pediatrics, Stanford University, Stanford. Copyright ©2012 102.
DeLuca D, Engle W, Jackson G. Transcutaneous bilirubinometry: hepatology research and clinical developments. New York: Nova Biomedical, 2013.
103.
Schumacher R. Transcutaneous bilirubinometry and diagnostic tests: "The rightjob for the tool". Pediatrics 2002; 110:407.
104.
Maisels MJ, Newman ТВ. Prevention, screening, and postnatal management of neonatal hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care of the jaundiced neonate. New York: McGraw Hill, 2012:175.
105.
Wainer S, Rabi Y, Parmar SM, et al. Impact of skin tone on the performance of a transcutaneous jaundice meter. Acta Paediatr 2009; 98:1909.
106.
Nagar G, Vandermeer B, Campbell S, et al. Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics 2013; 132:871.
107.
De Luca D, Jackson GL, Tridente A, et al. Trans cutaneous bilirubin nomograms: a systematic review of population differences and analysis of bilirubin kinetics. Arch
Pediatr Adolesc Med 2009; 163(11):1054.
108.
Poland RL, Hartenberger C, McHenry H, et al. Comparison of skin sites for estimating serum total bilirubin in in-patients and out-patients: chest is superior to brow. J
Perinatol 2004;24:541.
109.
Yaser A, Tooke L, Rhoda N. Interscapular site for transcutaneous bilirubin measurement in preterm infants: a better and safer screening site. J Perinatol
2014;34:209.
110.
Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 35 or more weeks' of gestation. Pediatrics 2006; 117:1169.
111.
Tan KL, Dong F. Transcutaneous bilirubinometry during and after phototherapy.
Acta Paediatr 2003;92:327.
112.
Brumbaugh JE, Gourley GR. Bilirubin and its various fractions. In: Stevenson
DK, Maisels MJ, Watchko JF, eds. Care ofthe jaundiced neonate. New York: McGraw
Hill, 2012:41.

перейти в каталог файлов